DE69432309D1 - Verfahren zur herstellung von immunoglobulinen aus colostrum und deren verwendung in pharmazeutischen zusammensetzungen - Google Patents

Verfahren zur herstellung von immunoglobulinen aus colostrum und deren verwendung in pharmazeutischen zusammensetzungen

Info

Publication number
DE69432309D1
DE69432309D1 DE69432309T DE69432309T DE69432309D1 DE 69432309 D1 DE69432309 D1 DE 69432309D1 DE 69432309 T DE69432309 T DE 69432309T DE 69432309 T DE69432309 T DE 69432309T DE 69432309 D1 DE69432309 D1 DE 69432309D1
Authority
DE
Germany
Prior art keywords
pct
immunoglobulines
colostrum
producing
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69432309T
Other languages
English (en)
Inventor
Conor John Graham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immuron Ltd
Original Assignee
Anadis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadis Ltd filed Critical Anadis Ltd
Application granted granted Critical
Publication of DE69432309D1 publication Critical patent/DE69432309D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DE69432309T 1993-09-20 1994-09-20 Verfahren zur herstellung von immunoglobulinen aus colostrum und deren verwendung in pharmazeutischen zusammensetzungen Expired - Lifetime DE69432309D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM131393 1993-09-20
PCT/AU1994/000562 WO1995008562A1 (en) 1993-09-20 1994-09-20 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition

Publications (1)

Publication Number Publication Date
DE69432309D1 true DE69432309D1 (de) 2003-04-24

Family

ID=3777213

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69432309T Expired - Lifetime DE69432309D1 (de) 1993-09-20 1994-09-20 Verfahren zur herstellung von immunoglobulinen aus colostrum und deren verwendung in pharmazeutischen zusammensetzungen

Country Status (8)

Country Link
US (1) US5780028A (de)
EP (1) EP0725789B1 (de)
JP (1) JPH09503754A (de)
AT (1) ATE234855T1 (de)
CA (1) CA2171607A1 (de)
DE (1) DE69432309D1 (de)
NZ (1) NZ273865A (de)
WO (1) WO1995008562A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
DK0934073T3 (da) * 1996-06-28 2003-05-05 Valio Oy Farmaceutisk sammensætning indeholdende komplementproteiner til behandling af Heliobacter infektioner og en fremgangsmåde til fremstilling af sammensætningen
DE19641466A1 (de) * 1996-10-09 1998-04-16 Biotest Pharma Gmbh Orale Anwendung eines Immunglobulinpräparates zur Prävention des Hämolytischen Urämischen Syndroms sowie Präparat hierfür
TR200200477T2 (tr) * 1999-08-24 2002-06-21 Teva Pharmaceutical Industries Limited Bir aşı kompozisyonu ve kullanım yöntemi.
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
BRPI0108145B8 (pt) * 2000-02-10 2021-05-25 Bpsi Holdings Inc composições de revestimento entérico acrílicas
JP4592041B2 (ja) * 2000-11-24 2010-12-01 株式会社Ｎｒｌファーマ 生活の質を改善する新規食品の製造法および用途
AU2003901008A0 (en) 2003-03-04 2003-03-20 Anadis Ltd Composition for the treatment and prevention of bacterial infections
US20080114212A1 (en) 2006-10-10 2008-05-15 General Electric Company Detecting surgical phases and/or interventions
WO2005003173A1 (en) * 2003-07-07 2005-01-13 Luiz Fernando Mesquita Process of obtaining a freeze-dried complex from mammal gland secretion
JP2008540462A (ja) * 2005-05-10 2008-11-20 マレー ゴールバーン コーオペラティブ コー リミテッド 免疫グロブリン分画およびそのためのプロセス
US20070087002A1 (en) * 2005-10-14 2007-04-19 Green Shawn J Anticholesterol immunoglobulin to treat lipid raft diseases
JP5175410B2 (ja) * 2005-11-01 2013-04-03 アサマ化成株式会社 新規な機能を有する錠菓、錠剤およびそれらの製造方法
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
EP2725035A1 (de) 2007-10-02 2014-04-30 Avaxia Biologics, Inc. Antikörpertherapie zur Verwendung im Verdauungstrakt
NZ587901A (en) 2008-03-13 2012-11-30 Immuron Ltd Immuno-modulating compositions for the treatment of immune-mediated disorders
EA024697B1 (ru) 2009-04-27 2016-10-31 Иммурон Лимитед Применение композиции, содержащей обогащенный анти-lps-антителами иммуноглобулиновый препарат, для лечения заболеваний печени
US9943597B2 (en) 2010-08-17 2018-04-17 Immuron Limited Anti-LPS enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
CA2813612A1 (en) * 2010-10-04 2012-04-12 Immuron Limited Methods and compositions using anti-lps ligands for the treatment and prevention of inflammatory disorders
US9474715B2 (en) * 2011-11-30 2016-10-25 Andreas Voigt Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition
AU2017240190A1 (en) * 2016-03-31 2018-09-20 Sorriso Pharmaceuticals, Inc. Compositions
EP3459528B1 (de) 2017-09-20 2022-11-23 Tillotts Pharma Ag Herstellung von festen darreichungsformen mit antikörpern durch lösungs-/suspensionsschichtung
WO2019097251A1 (en) * 2017-11-17 2019-05-23 Intract Pharma Limited Novel compositions
CN114466864A (zh) 2019-06-21 2022-05-10 索瑞索制药公司 多肽
CN114514243A (zh) 2019-06-21 2022-05-17 索瑞索制药公司 多肽
CZ309222B6 (cs) * 2019-08-30 2022-06-01 DAVID DREAM s.r.o. Výživový doplněk stravy obsahující granulované kolostrum

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892865A (en) * 1972-02-09 1975-07-01 Dan Christian Roehm Method of controlling lipids in the bloodstream
US4051235A (en) * 1976-04-22 1977-09-27 Plymate Robert R Method of preparing bovine colostrum for use in treating livestock
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin
US4289751A (en) * 1979-06-29 1981-09-15 Merck & Co., Inc. Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof
US4377569A (en) * 1980-01-21 1983-03-22 Plymate Robert R Method of treating animals to resist infectious diseases
JPS5742629A (en) * 1980-08-29 1982-03-10 Sendai Biseibutsu Kenkyusho Remedy for refractory diseases
ZA836349B (en) * 1982-09-02 1985-04-24 Unilever Plc Production of antibodies
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4882167A (en) * 1983-05-31 1989-11-21 Jang Choong Gook Dry direct compression compositions for controlled release dosage forms
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
GB8502006D0 (en) * 1985-01-26 1985-02-27 Ciba Geigy Ag Polypeptide factors from colostrum
US4863875A (en) * 1985-08-26 1989-09-05 Gia Research Company, L.P. Dye labelled antibodies as reagents for use in immunoassay systems
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus
US5017372A (en) * 1986-04-14 1991-05-21 Medicis Corporation Method of producing antibody-fortified dry whey
ATE90569T1 (de) * 1988-04-19 1993-07-15 Biotest Pharma Gmbh Praeparat mit antikoerperaktivitaet und breitem wirkungsspektrum, daraus bestehende oder diese enthaltende mittel und deren verwendung zur behandlung von bakteriell oder toxin-bedingten erkrankungen und zur bekaempfung von protozoen.
US5225330A (en) * 1988-08-01 1993-07-06 The United States Of America As Represented By The Department Of Health And Human Services Diagnostic kit and diagnostic method utilizing carbohydrate receptors
AU5254790A (en) * 1989-04-06 1990-10-11 Chugai Seiyaku Kabushiki Kaisha Process for preparing a therapeutic agent for rotavirus infection
IE76730B1 (en) * 1990-07-30 1997-11-05 Abbott Laboraties Method and product for the treatment of gastric disease
JPH04169539A (ja) * 1990-11-01 1992-06-17 Imuno Japan:Kk 消化器疾患治療・予防剤およびその製造方法
FI91166C (fi) * 1991-10-17 1994-05-25 Valio Biotuotteet Oy Ternimaitofraktio, menetelmä sen valmistamiseksi ja sen käyttö kasvualustojen täydennysaineena
WO1993010818A1 (en) * 1991-12-04 1993-06-10 New England Medical Center Hospitals, Inc. Infant formula and infant formula additives
EP0706400A1 (de) * 1993-03-15 1996-04-17 Pharma Pacific Pty. Ltd. Therapeutische formulierung und verfahren

Also Published As

Publication number Publication date
NZ273865A (en) 1997-12-19
CA2171607A1 (en) 1995-03-30
EP0725789A1 (de) 1996-08-14
WO1995008562A1 (en) 1995-03-30
JPH09503754A (ja) 1997-04-15
ATE234855T1 (de) 2003-04-15
US5780028A (en) 1998-07-14
EP0725789A4 (de) 1999-07-28
EP0725789B1 (de) 2003-03-19

Similar Documents

Publication Publication Date Title
DE69432309D1 (de) Verfahren zur herstellung von immunoglobulinen aus colostrum und deren verwendung in pharmazeutischen zusammensetzungen
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
FI960102A0 (fi) Uusi farmaseuttinen seos
ATE170630T1 (de) Proteine mit geänderten epitopen und verfahren zur deren herstellung
ATE296315T1 (de) Galactosylierte glykoproteine enthaltende zusammensetzungen und verfahren zur deren herstellung
HK1012841A1 (en) Pharmaceutical composition for the treatment or prevention of amalignant tumor
ATE118798T1 (de) Verfahren zur agglomerierung wasserquellbarer polymere durch sintergranulation.
BR9407239A (pt) Azadioxacicloalquenos substituídos
DE69032806D1 (de) Verfahren zur isolierung und reinigung von rezeptoren für transferrin und lactoferrin von bakterien und herstellung von impfstoffen, die sie enthalten
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
DE60221799D1 (de) Verfahren zur herstellung von verbundmaterialien, die naturbindemittel enthalten
FI972703A0 (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
DE69425246D1 (de) Monoklonale antikoerper gegen lfa-1 zur herstellung eines arzneimittels zur vorbeugung der transplantatabstossung von organen
ATE272116T1 (de) Polypeptide mit der möglichkeit rhesus d antigenspezifische bindungsstrukturen aus zu bilden, dafür kodierende dna und deren prozess der herstellung und anwendung
DE69104365D1 (de) Vaterit und verfahren zu dessen herstellung.
AU3078892A (en) Human interleukin-8 analogs
ATE6032T1 (de) Biologisch aktive substanzen, deren herstellung aus menschlichem kasein und zubereitungen, die sie enthalten.
DE69829191D1 (de) Verfahren zur herstellung pharmazeutischer zusammensetzungen von lipidpartikeln, enthaltend einen lipidwirkstoff sowie ein protein
DK0508993T3 (da) Farmaceutiske præparater indeholdende antigen-antistofkomplekser og anvendelse derfor
ATE182504T1 (de) Verfahren zur herstellung von formkörpern
DE69026087D1 (de) Substituierte 2-imidazoline und verfahren zur herstellung sowie deren verwendung
DE69932804D1 (de) Protein, welches durch einen cystinknoten charakterisiert ist und verfahren zu dessen herstellung
PT85830A (de) Neue monoklonale antikorper gegen ifn-omega verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega
ATE205473T1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
ATE43610T1 (de) Acino-foetale differenzierungsproteine verbunden mit krebs des pankreas, antiserum und monoklonale antikoerper gegen diese proteine und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
8332 No legal effect for de